Cigna Group $CI Shares Sold by Meyer Handelman Co.

Meyer Handelman Co. lowered its position in Cigna Group (NYSE:CI) by 53.5% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 5,193 shares of the health services provider’s stock after selling 5,982 shares during the quarter. Meyer Handelman Co.’s holdings in Cigna Group were worth $1,429,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also made changes to their positions in CI. Harbor Capital Advisors Inc. increased its holdings in Cigna Group by 119.5% during the 3rd quarter. Harbor Capital Advisors Inc. now owns 90 shares of the health services provider’s stock valued at $26,000 after acquiring an additional 49 shares in the last quarter. Beacon Financial Strategies CORP purchased a new stake in shares of Cigna Group in the fourth quarter valued at about $28,000. Collier Financial acquired a new stake in shares of Cigna Group in the third quarter valued at approximately $34,000. True Wealth Design LLC increased its stake in shares of Cigna Group by 116.4% during the 4th quarter. True Wealth Design LLC now owns 158 shares of the health services provider’s stock worth $43,000 after purchasing an additional 85 shares in the last quarter. Finally, Founders Capital Management raised its position in shares of Cigna Group by 53.0% during the 3rd quarter. Founders Capital Management now owns 153 shares of the health services provider’s stock worth $44,000 after purchasing an additional 53 shares during the last quarter. Institutional investors and hedge funds own 86.99% of the company’s stock.

Insider Activity

In other news, insider Everett Neville sold 1,719 shares of the company’s stock in a transaction dated Monday, March 2nd. The shares were sold at an average price of $288.91, for a total transaction of $496,636.29. Following the completion of the transaction, the insider owned 5,670 shares of the company’s stock, valued at $1,638,119.70. This represents a 23.26% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, insider Nicole S. Jones sold 2,307 shares of the stock in a transaction dated Monday, March 2nd. The stock was sold at an average price of $288.91, for a total transaction of $666,515.37. Following the transaction, the insider owned 32,647 shares in the company, valued at approximately $9,432,044.77. The trade was a 6.60% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Corporate insiders own 0.60% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities research analysts recently issued reports on the company. Barclays reduced their target price on Cigna Group from $305.00 to $303.00 and set an “overweight” rating on the stock in a research note on Friday, February 6th. UBS Group reissued a “buy” rating and issued a $375.00 price target on shares of Cigna Group in a report on Monday, February 9th. Piper Sandler reduced their price objective on Cigna Group from $374.00 to $370.00 and set an “overweight” rating on the stock in a research report on Tuesday, March 3rd. Leerink Partners increased their price objective on Cigna Group from $270.00 to $297.00 and gave the company a “market perform” rating in a research note on Friday, February 6th. Finally, Mizuho set a $325.00 price objective on Cigna Group in a research report on Friday, January 9th. One investment analyst has rated the stock with a Strong Buy rating, seventeen have given a Buy rating and four have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $333.11.

Cigna Group Stock Up 3.3%

Shares of NYSE CI opened at $266.54 on Wednesday. The firm has a market cap of $70.24 billion, a P/E ratio of 12.02, a price-to-earnings-growth ratio of 0.89 and a beta of 0.27. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.74 and a current ratio of 0.74. Cigna Group has a 1 year low of $239.51 and a 1 year high of $350.00. The firm’s 50 day moving average price is $276.72 and its 200 day moving average price is $279.57.

Cigna Group (NYSE:CI) last issued its quarterly earnings results on Thursday, February 5th. The health services provider reported $8.08 earnings per share for the quarter, beating the consensus estimate of $7.88 by $0.20. Cigna Group had a return on equity of 19.46% and a net margin of 2.17%.The company had revenue of $72.50 billion during the quarter, compared to the consensus estimate of $69.53 billion. During the same period in the previous year, the firm posted $6.64 EPS. Cigna Group’s revenue was up 10.4% on a year-over-year basis. Cigna Group has set its FY 2026 guidance at 30.250- EPS. As a group, sell-side analysts anticipate that Cigna Group will post 29.77 earnings per share for the current year.

Cigna Group Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Thursday, March 19th. Investors of record on Thursday, March 5th were given a dividend of $1.56 per share. This represents a $6.24 annualized dividend and a yield of 2.3%. This is a boost from Cigna Group’s previous quarterly dividend of $1.51. The ex-dividend date was Thursday, March 5th. Cigna Group’s dividend payout ratio (DPR) is currently 28.13%.

Cigna Group Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.